Recovery

Recovery is a pre-clinical stage biotechnology company focused on developing therapies to treat muscle wasting and metabolic disorders. The company's primary mission is to address conditions such as cachexia and sarcopenia by leveraging novel mechanisms that promote muscle growth and metabolic health. Their pipeline includes small molecule and peptide-based candidates designed to modulate key metabolic pathways, including the ghrelin and GLP-1 systems. By targeting the underlying drivers of muscle loss, Recovery aims to improve the quality of life and clinical outcomes for patients with chronic diseases and age-related decline.